FDA Inspection
Medical Ventures, Inc.Medical Ventures, Inc. – FDA Inspection, Feb 1, 2012
Record Details
This FDA Inspection record concerns Medical Ventures, Inc., with an inspection on February 1, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Medical Ventures, Inc.
- Inspection Date
- February 1, 2012
- Product Type
- Biologics
View Company Profile
ID · efd397e8-474a-4fb5-b449-415a7456fdb2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 766134
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.265(f)Return to inventory--procedures
- 21 CFR 1271.260(e)Periodic review of temperatures
- 21 CFR 1271.200(c)Calibration procedures and schedules (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medical Ventures, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 15, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Medical Ventures, Inc.
- FDA Inspection 871532 - 2014-03-26
- FDA Inspection 635319 - 2009-12-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.